U.S. health regulator pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant

5 hours ago 1

A warning letter issued by the USFDA usually identifies the violation, such as poor manufacturing practices, problems with claims for what a product can do, or incorrect directions for use

Read Entire Article

U.S. health regulator pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant

Related

Driverless train for Bengaluru Metro’s Yellow Line set for s...

Nature camp held for govt school students of Pudukottai

Mehbooba slams J&K Assembly speaker, accuses him of imposing...

Trending

Popular

Punjab FC signs Argentine midfielder Ezequiel Vidal

BJP meet decides to build on the impressive LS election perf...

My fight has just begun, says Vinesh Phogat after Haryana kh...

Assam’s Bodoland University offers course for farmers who ne...

Government approves 40% risk allowance for NDRF rescuers, sa...